Oncopharmacological perspectives of a plant lectin (Viscum album agglutinin-I): Overview of recent results from in vitro experiments and in vivo animal models, and their possible relevance for clinical applications

Evidence-based Complementary and Alternative Medicine

Volumn 2, Issue 1, 2005, Pages 59-67

  Hajtó, Tibor ^a   Hostanska, Katarina ^b   Berki, Timea ^a   Pálinkás, László ^a   Boldizsár, Ferenc ^a   Németh, Péter ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BONE MARROW CELL; CANCER; CANCER MODEL; CANCER PATIENT; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOSTASIS; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SENSITIVITY; DRUG STRUCTURE; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THYMOCYTE; VISCUM ALBUM;

EID: 25844444123     PISSN: 1741427X     EISSN: None     Source Type: Journal    
DOI: 10.1093/ecam/neh058     Document Type: Review

References (81)

1. Hajto T, Hostanska K, Gabius H-J. Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 1989;49:4803-8.
2. Samuelsson G, Pettersson B. Separation of viscotoxins from the European mistletoe Viscum album L (Loranthacea) by chromatography on sulfoethyl sephadex. Acta Chem Scand 1970;24:2751-6.
3. Urech K, Schaller G, Ziska P, Giannattasio M. Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumor cells in culture. Phytother Res 1995;9:49-55.
4. Müller EA, Anderer FA. A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon-gamma inducer. Cancer Immunol Immunother 1990;32:221-7.
5. Sakurai A, Okumara Y. Chemical studies on the mistletoe. The structure of taxillusin, a new flavinoid glycoside isolated from Taxillus kaempferi. Bull Chem Soc Jpn 1983;56:542-4.
6. Becker H, Exner J. Vergleichende Untersuchungen von Misteln verschiedener Wirtsbäume an Hand der Flavonoide und Phenyl-carbonsäuren. Z Pflanzenphysiol 1980;97:417-28.
7. Franz M, Vollmer S, Wacker R et al. Isolation and quantification of chitin-binding mistletoe lectin from mistletoe extracts and validation of these methods. Drug Res 2004;54:230-9.
8. Vester F, Mai W. Zur Kenntnis der Inhaltsstoffe von Viscum album. Freie Aminosäuren. Hoppe-Seyler's Z Physiol Chem 1980;322:273-7.
9. Sharon N. Carbohydrates as recognition determinants in phagocytosis and in lectin-mediated killing of target cells. Biol Cell 1984;51:239-46.
10. Ziska P, Franz H. Determination of lectin contents in commercial mistletoe preparations for cancer therapy using the ELISA technique. In: Bog Hansen TC, Breborowicz J (eds). Lectins, Vol. IV. Walter de Gruyter & Co., Berlin, 1985, 473-80.
11. Dietrich JB, Ribereau-Gayon G, Jung ML, Franz H, Beck JP, Anton R. Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. Anticancer Drug 1992;3:507-11.
12. Olsnes S, Stirpe F, Sandvig K, Pihl A. Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). J Biol Chem 1982;257:13263-70.
13. Holtskog R, Sandvig K, Olsnes S. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties. Oncology 1988;45:172-9.
14. Franz H. Mistletoe lectins and their A and B chains. Oncology 1986;43:23-34.
15. Samtleben R, Kiefer M, Luther P. Characterization of the different lectins from Viscum album (mistletoe) and their structural relationship with agglutinins from Abrus precatorius and Ricinus communis. In: Bog Hansen TC, Breborowicz J (eds). Lectins, Vol. IV. Walter de Gruyter & Co., Berlin, 1985, 617-26.
16. Bushueva TL, Tonevitsky AG. Similarity of protein conformation at low pH and high temperature observed for B-chains of two plant toxins: ricin and mistletoe lectin I. FEBS Lett 1988;229:119-122.
17. Luther P, Uhlenbruck G, Reutgen H, Samtleben R, Sehrt I, Ribereau-Gayon G. Are lectins of Viscum album interesting tools in lung diseases? A review of recent results. Z Erkr Atmungsorgane 1986;166:247-56.
18. Lee RT, Gabius H-J, Lee YC. The sugar-combining area of the galactose-specific toxic lectin of mistletoe extends beyond the terminal sugar residue: comparison with homologous toxic lectin, ricin. Carbohydr Res 1994;254:269-76.
19. Endo Y, Tsurugi K, Franz H. The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes. The RNA N-glycosidase activity of the protein. FEBS Lett 1988;231:378-80.
20. Sandvig K, Olsnes S. Entry of the toxic proteins abrin, modeccin, ricin and diphtheria toxin into the cell. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J Biol Chem 1982;257:7504-13.
21. Wiedlocha A, Sandvig K, Walzel H, Radzikowsky C, Olsnes S. Internalization and action of an immunotoxin containing mistletoe lectin A-chain. Cancer Res 1991;51:916-20.
22. Stirpe F, Barbieri L, Batelli MG, Soria M, Lappi DA. Ribosome- inactivating proteins from plants: present status and future prospects. BioTechnology 1992;10:405-12.
23. Soler MH, Stoeva S, Schwamborn C, Wilhelm S, Stiefel T, Voelter W. Complete amino acid sequence of the A chain of mistletoe lectin 1. FEBS Lett 1996;399:153-7.
24. Soler MH, Stoeva S, Voelter W. Complete fluid acid sequence of the B chain of mistletoe lectin I. Biochem Biophys Res Commun 1998;246:596-601.
25. Zinke H, Eck J, Langer M, Möckel B, Baur A, Lentzen H. Molecular cloning of the Viscum album L (mistletoe) gene for ML-1 and characterization of the recombinant protein. Phytomedicine 1996;3 Suppl 1: 25.
26. Hostanska K, Hajto T, Fischer J et al. Selective modulation of phosphatitylserine expression on various subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin VAA-I and its recombinant form (rVAA) in vitro. Cancer Detect Prevent 1999;23:511-23.
27. Hajto T, Hostanska K, Weber K et al. Effect of a recombinant lectin, Viscum album agglutinin (rVAA) on secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK cell-mediated cytotoxicity of rat splenocytes in vitro and in in vivo. Nat Immunol 1998;16:34-46.
28. Janssen O, Scheffler A, Kabelitz D. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Drug Res 1993;43:1221-7
29. Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K. Induction of apoptosis in human lymphocytes treated with Viscum album L is mediated by mistletoe lectins. Cancer Lett 1996;99:59-72.
30. Hajto T, Hostanska K, Frei K, Rordorf C, Gabius H-J. Increased secretion of tumor necrosis factor α, interleukin 1, and interleukin 6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied misletoe extract. Cancer Res 1990;50:3322-6.
31. Hostanska K, Hajto T, Spagnoli G, Fischer J, Lentzen H, Herrmann R. A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immunol 1995;14:295-304.
32. Hostanska K, Hajto T, Weber K et al. A natural immunity activating plant lectin, Viscum album agglutinin-I (VAA-I) induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Nat Immunol 1996-97;15:295-311.
33. Wenzel-Seifert K, Lentzen H, Seifert R. In U-937 peomonocytes, mistletoe lectin I increases basal (Ca2+)i, enhances histamin H1- and complement C5a-receptor-mediated rises in (Ca2+)i, and induces cell death. Naunyn-Schmiedeberg's Arch Pharmacol 1997;355:190-7.
34. Bantel H, Engels I, Voelter W, Schulze-Osthoff K, Wesselborg S. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 1999;59:2083-90.
35. Hostanska K, Vuong V, Rocha S et al. Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionizing radiation. Br J Cancer 2003;88:1785-92.
36. Savoie A, Lavastre V, Pelletier M, Hajto T, Hostanska K, Girard D. Activation of human neutrophils by the plant lectin Viscum album agglutinin-I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis. J Leukoc Biol 2000;68:845-53.
37. Lavastre V, Pelletier M, Saller R, Hostanska K, Girard D. Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. J Immunol 2002;168:1419-27.
38. Lavastre V, Cavalli H, Ratthe C, Girard G. Anti-inflammatory effect of Viscum album agglutinin-I (VAA-I): induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophil inflammation in vivo. Clin Exp Immunol 2004;137:272-8.
39. Kim M, Rao MV, Tweardy DJ, Prakash M, Galili U, Gorelik E. Lectin-induced apoptosis of tumor cells. Glycobiology 1993;3:447-53.
40. Männel DN, Becker H, Gundt A, Kist A, Franz H. Induction of tumor necrosis factor expression by a lectin from Viscum album. Cancer Immunol Immunother 1991;33:177-82.
41. Ribereau-Gayon G, Dumont S, Müller C, Jung ML, Poindron P, Anton R. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett 1996;109:33-8.
42. Walzel H, Bremer H, Gabius H-J. Lectin-induced alterations in the level of phospholipids, inositol phosphates, and phosphoproteins. In: Gabius H-J, Gabius S (eds). Lectins and Glycobiology. Springer Verlag, Berlin, 1993, 357-61.
43. Muthing J, Meisen I, Bullau P et al. Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues. Biochemistry 2004;43:2996-3007.
44. Joller PW, Menrad JM, Schwarz T et al. Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay. Drug Res 1996;46:649-53.
45. Gorter RW, Joller P, Stoss M. Cytokine release of a keratinocyte model after incubation with two different Viscum album L extracts. Am J Ther 2003;10:40-7.
46. Huang M, Stolina M, Sharma S et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998;58:1208-16.
47. Manetti R, Parronchi P, Guidizi MG et al. Natural killer cell stimulating factor (IL-12) induces T helper type (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-204.
48. Pelletier M, Lavastre V, Savoie A et al. Modulation of interleukin-15-induced human neutrophil responses by the plant lectin Viscum album agglutinin-I. Clin Immunol 2001;101:229-236.
49. Metzner G, Franz H, Kindt A, Fahlbusch B, Süss J. The in vitro activity of lectin from mistletoe (ML-I) and its isolated A and B chains on functions of macrophages and poly-morphonuclear cells. Immunobiology 1985;169:461-71.
50. Timoshenko AV, Gabius HJ. Efficient induction of superoxide release from human neutrophils by the galactoside-specific lectin from Viscum album. Biol Chem Hoppe-Seyler 1993;374:237-43.
51. Wenzel-Seifert K, Krautwurst D, Lentzen H, Seifert R. Concavalin A and mistletoe lectin I differentially activate cation entry and exocytosis in human neutrophils: lectins may activate multiple subtypes of cation channels. J Leukoc Biol 1996;60:345-55.
52. Baxevanis CN, Voutsas LF, Soler MH et al. Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity. Immunopharmacol Immunotoxicol 1998;20:355-72.
53. Vehmeyer K, Hajto T, Hostanska K et al. Lectin-induced increase in clonogenic growth of hematopoietic progenitor cells. Eur J Hematol 1998;60:16-20.
54. Beuth J, Ko HL, Tunggal L et al. Immunaktive Wirkung von Mistellektin 1 in Abhängigkeit von der Dosierung. Arzneim Forsch 1994;44:1255-8.
55. Beuth J, Stoffel B, Ko HL, Buss G, Tunggal L, Pulverer G. Immunaktive Wirkung verschiedener Mistellektin-1 Dosierungen in Mammakarzinompatientinennen. Arzneim Forsch 1995;45:505-7.
56. Hajto T, Hostanska K, Herrmann R. Immunomodulatory potency of mistletoe lectins in cancer patients. Results of a dose finding study. Allergy (Suppl) 1993;48:548.
57. Hajto T, Hostanska K, Gabius H-J. Zytokine als Lektin-induzierte Mediatoren in der Misteltherapie. Therapeutikon 1990;4:136-45.
58. Ziska P, Gelbin M, Franz H. Interaction of mistletoe lectins ML-I, ML-II, and ML-III with carbohydrates. In: Van Driessche E, Franz H, Beeckmans R, Pfüller U, Kallikorm A, Bog-Hansen TC (eds). Lectins: Biology Biochemistry, Clinical Biochemistry, Vol. 8. Walter de Gruyter & Co., Berlin, 1993, 10-3.
59. Fernandez T, Cerdà Zolezzi P, Caldas Lopes E et al. Immunobiological features of the galactoside lectin L-Lc isolated from the Argentine mistletoe Ligaria cuneifolia. J Ethnopharmacol 2003;85:81-92.
60. Beuth J, Ko HL, Gabius HJ, Burrichter H, Oette K, Pulverer G. Behaviour of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Invest 1992;70:658-61.
61. Beuth J, Gabius HJ, Steuer MK et al Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients. Med Klin 1993;88:287-90.
62. Beuth J, Ko HL, Tunggal L, Geisel J, Pulverer G. Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract. Arznem Forsch 1993;43:166-9.
63. Mayer H, Steppkes R, Roth R, Richter C-P. Mistelextrakte zur Immunmodulation bei Tumorpatienten. Pharm Zeitung 1996;141:11-23.
64. Hajto T, Hostanska K, Fischer J, Lentzen H. Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific lectin from Viscum album plant extract. Phytomedicine 1996;3:129-37.
65. Hajto T, Hostanska K, Steinberg F, Gabius H-J. Galactoside-specific lectin from clinically applied mistletoe extract reduces tumor growth by augmentation of host defense system. Blut 1990;61:164.
66. Hajto T, Hostanska K, Fornalski M, Kirsch A. Antitumorale Aktivität des immunmodu-latorisch wirkenden Beta-galaktosidspezifischen Mistellektins bei der klinischen Anwendung von Mistelextrakten (Iscador). Dtsch Zschr Onkol 1991;23:1-6.
67. Heiny BM, Beuth J. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 1994;14:1339-1342.
68. Heiny BM, Albrecht V, Beuth J. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res 1998;18:583-6.
69. Hajtó T, Berki T, Boldizsár F, Németh P. Galactoside-specific plant lectin, Viscum album agglutinin-I induces enhanced proliferation and apoptosis of murine thymocytes in vivo. Immunol Lett 2003;86:23-7.
70. Hajtó T, Berki T, Pálinkás L, Boldizsár F, Nagy G, Németh P. Galactoside-specific misletoe lectin modulate the dexamethasone-induced apoptosis and glucocorticoid receptor level in Balb/c thymocytes. In vivo 2003;17:163-8.
71. Weber K, Mengs U, Schwarz T et al. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs. Arznem Forsch 1998;48:497-502.
72. Lenartz D; Dott U, Menzel J, Schierholz JM, Beuth J. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res 2000;20:2073-6.
73. Heiny BM, Albrecht V, Beuth J. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res 1998;18:583-6.
74. Lenartz D, Stoffel B, Menzel J, Beuth J. Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res 1996;16:799-802.
75. Beuth J, Ko HL, Tunggal L et al. Immuno-protective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice. In vivo 1994;8:989-92.
76. Weber K, Mengs U, Schwarz T, Becker H, Lentzen H. Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice. Arzneim Forsch 1996;46:1174-8.
77. Stoffel B, Beuth J, Pulverer G. Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listerosis. Zentralbl Bakteriol 1996;284:439-42.
78. Kovacs E, Hajto T, Hostanska K. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer 1991;27:1672-6.
79. Mengs U, Göthel D, Leng-Peschlow E. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research. Anticancer Res 2002;22:1399-408.
80. Yoon TJ, Yoo YC, Kang TB et al. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells. Arch Pharm Res 2003;26:861-7.
81. Elsasser-Beile U, Ruhnau T, Freudenberg N, Wetterauer U, Mengs U. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model. Cancer 2001;91:998-1004.